E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


A profile of adverse drug reactions in a rural tertiary care hospital

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila.

Abstract
Background: Adverse drug reactions (ADRs) are a great concern in therapeutics. ADRs were ranked between the fourth and sixth leading causes of death in the USA.

Aims and Objectives: The present study was conducted with the aim of identifying, analyzing the causality, pattern, and severity of ADRs occurring in our institution.

Materials and Methods: A non-interventional observational study was conducted over 1 year from January to December 2015. The yellow forms dropped in the red ADR boxes are collected and analyzed for demographic data, causality, severity, drugs implicated, and organ system affected. The data were presented as numbers and percentages.

Results: Antimicrobials are the most common drug class implicated in ADRs, and the dermatological system was the most common system affected by ADRs. All the reactions either belonged to the probable or possible category. Majority of reactions were nonserious.

Conclusion: 175 ADRs were reported, which shows reporting was adequate. Awareness should be increased among health-care professionals regarding polypharmacy, which helps in reducing the ADR incidence.

Key words: Pharmacovigilance, Causality, Adverse drug reactions, severity


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shivaraj Basavaraj Patil
Articles by Shrinivas R Raikar
Articles by Marupaka Janardhan
Articles by Y Venkata rao
Articles by Bhaskar H N
Articles by Nallavelly Vahila
on Google
on Google Scholar


REFERENCES
1. Mandavi, D'Cruz S, Sachdev A, Tiwari P. Adverse drug reactions & their risk factors among Indian ambulatory elderly patients. Indian J Med Res. 2012;136(3):404-10.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5. https://doi.org/10.1001/jama.279.15.1200 [Pubmed]   
3. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital – Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12(8):687-92. https://doi.org/10.1002/pds.871 [Pubmed]   
4. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008;65(2):210-6. https://doi.org/10.1111/j.1365-2125.2007.02993.x [Pubmed]    [PMC Free Fulltext]   
5. Verma R, Tiwari S, Gupta CM, Verma N. Cutaneous adverse drug reactions-A study of clinical patterns, causality, severity & preventability. J Dent Med Sci. 2014;13(7):102-9.
6. Shareef SM, Naidu CD, Raikar SR, Rao YV, Devika U. Development, implementation and analysis of adverse drug reaction monitoring system in a rural tertiary care teaching hospital in Narketpally, Telangana. Int J Basic Clin Pharmacol. 2015;4(4):757-60. https://doi.org/10.18203/2319-2003.ijbcp20150386
7. Santosh KC, Tragulpiankit P. Pharmacovigilance: An overview. Mahidol Univ J Pharm Sci. 2011;38(1-2):1-7.
8. Härmark L, van Grootheest AC. Pharmacovigilance: Methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743-52. https://doi.org/10.1007/s00228-008-0475-9 [Pubmed]   
9. Pharmacovigilance Programme of India. CDSCO, Ministry of Health and Family Welfare, Government of India. Ghaziabad: Pharmacovigilance Programme of India; 2010.
10. The Use of the WHO-UMC System for Standardised Case Causality Assessment. Available from: http://www.who-umc. Org/Graphics/24734.pdf. [Last accessed on 2016 Mar 02].
11. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229-32.
12. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316(7140):1295-8. https://doi.org/10.1136/bmj.316.7140.1295 [Pubmed]    [PMC Free Fulltext]   
13. Shamna M, Dilip C, Ajmal M, Linu Mohan P, Shinu C, Jafer CP, et al. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014;22(4):303-8. https://doi.org/10.1016/j.jsps.2013.06.004 [Pubmed]    [PMC Free Fulltext]   
14. Swamy S, Bhanuprakash, Nadig P, Muralimohan, Shetty M. Profile of suspect adverse drug reactions in a teaching tertiary care hospital. J Pharmacol Clin Toxicol. 2013;1(1):1005.
15. Patidar D, Rajput MS, Nirmal NP, Savitri W. Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, India. Interdiscip Toxicol. 2013;6(1):41-6. https://doi.org/10.2478/intox-2013-0008 [Pubmed]    [PMC Free Fulltext]   
16. Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC. Adverse drug reaction monitoring: Support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacol Toxicol. 2013;14:5. https://doi.org/10.1186/2050-6511-14-5 [Pubmed]    [PMC Free Fulltext]   
17. Dutta SB, Beg MA, Bawa S, Anjoom M, Varma A, Singh NK, et al. A retrospective analysis of adverse drug reactions in a tertiary care teaching hospital at Dehradun, Uttarakhand. Int J Basic Clin Pharmacol. 2015;4(1):121-4. https://doi.org/10.5455/2319-2003.ijbcp20150221

How to Cite this Article
Pubmed Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. A profile of adverse drug reactions in a rural tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2016; 6(6): 559-562. doi:10.5455/njppp.2016.6.0514317062016


Web Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. A profile of adverse drug reactions in a rural tertiary care hospital. https://www.njppp.com/?mno=230280 [Access: December 03, 2022]. doi:10.5455/njppp.2016.6.0514317062016


AMA (American Medical Association) Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. A profile of adverse drug reactions in a rural tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2016; 6(6): 559-562. doi:10.5455/njppp.2016.6.0514317062016



Vancouver/ICMJE Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. A profile of adverse drug reactions in a rural tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2016), [cited December 03, 2022]; 6(6): 559-562. doi:10.5455/njppp.2016.6.0514317062016



Harvard Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila (2016) A profile of adverse drug reactions in a rural tertiary care hospital. Natl J Physiol Pharm Pharmacol, 6 (6), 559-562. doi:10.5455/njppp.2016.6.0514317062016



Turabian Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. 2016. A profile of adverse drug reactions in a rural tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 6 (6), 559-562. doi:10.5455/njppp.2016.6.0514317062016



Chicago Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. "A profile of adverse drug reactions in a rural tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 6 (2016), 559-562. doi:10.5455/njppp.2016.6.0514317062016



MLA (The Modern Language Association) Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila. "A profile of adverse drug reactions in a rural tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 6.6 (2016), 559-562. Print. doi:10.5455/njppp.2016.6.0514317062016



APA (American Psychological Association) Style

Shivaraj Basavaraj Patil, Shrinivas R Raikar, Marupaka Janardhan, Y Venkata rao, Bhaskar H N, Nallavelly Vahila (2016) A profile of adverse drug reactions in a rural tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 6 (6), 559-562. doi:10.5455/njppp.2016.6.0514317062016